Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Wenhao Shi, Tingting Jiang, Paolo Giovanni Nuciforo et al. · Annals of Oncology · 2016

Cited by 76 works. doi:10.1093/annonc/mdw434 Open-access PDF

Authors

References